Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
Artificial intelligence can solve problems at remarkable speed, but it's the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists ...
Machine Learning to Predict Tamoxifen Nonadherence Among US Commercially Insured Patients With Metastatic Breast Cancer Ideally, specific treatment for a cancer patient is decided by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results